Literature DB >> 25274159

Sex-determination gene SRY potentially associates with poor prognosis but not sex bias in hepatocellular carcinoma.

Tong-Chun Xue1, Lan Zhang, Zheng-Gang Ren, Rong-Xin Chen, Jie-Feng Cui, Ning-Ling Ge, Sheng-Long Ye.   

Abstract

BACKGROUND: Gender disparity is well known in hepatocellular carcinoma (HCC). SRY is a critical sex-determination gene involved in embryonic development. AIM: The potential relevance of SRY to HCC progression was evaluated.
METHODS: SRY expression in HCC cell lines and tissues was evaluated. Invasion and wound healing assays were used to evaluate the role of SRY in HCC cell migration. The prognostic value of SRY for HCC patient survival was evaluated.
RESULTS: SRY was highly expressed in HCC cell lines and tumor tissues. Downregulation of SRY expression decreased migration and invasion potential of HCC cells. High SRY levels correlated with poor HCC patient survival. Additionally, neither spatial position nor expression intensity of SRY was correlated with HCC gender disparity.
CONCLUSIONS: High levels of SRY expression correlated with cancer progression and poor HCC patient survival. However, high SRY levels are not significantly correlated with HCC sex bias.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25274159     DOI: 10.1007/s10620-014-3377-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

1.  Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.

Authors:  Silvia Tremosini; Alejandro Forner; Loreto Boix; Ramon Vilana; Luis Bianchi; Maria Reig; Jordi Rimola; Carlos Rodríguez-Lope; Carmen Ayuso; Manel Solé; Jordi Bruix
Journal:  Gut       Date:  2012-01-27       Impact factor: 23.059

2.  CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.

Authors:  Xin-Rong Yang; Yang Xu; Bin Yu; Jian Zhou; Jia-Chu Li; Shuang-Jian Qiu; Ying-Hong Shi; Xiao-Ying Wang; Zhi Dai; Guo-Ming Shi; Bin Wu; Li-Ming Wu; Guo-Huan Yang; Bo-Heng Zhang; Wen-Xin Qin; Jia Fan
Journal:  Clin Cancer Res       Date:  2009-08-25       Impact factor: 12.531

3.  Expression of SRY gene transcripts with a longer 3' untranslated sequence in adult human male lymphocytes and tumor cells.

Authors:  Y Kimoto
Journal:  Mol Gen Genet       Date:  1998-03

4.  Gender disparity of hepatocellular carcinoma: the roles of sex hormones.

Authors:  Shiou-Hwei Yeh; Pei-Jer Chen
Journal:  Oncology       Date:  2010-07-08       Impact factor: 2.935

5.  Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C.

Authors:  Yen-Tsung Huang; Chin-Lan Jen; Hwai-I Yang; Mei-Hsuan Lee; Jun Su; Sheng-Nan Lu; Uchenna H Iloeje; Chien-Jen Chen
Journal:  J Clin Oncol       Date:  2011-08-22       Impact factor: 44.544

6.  Novel transcriptional targets of the SRY-HMG box transcription factor SOX4 link its expression to the development of small cell lung cancer.

Authors:  Sandra D Castillo; Ander Matheu; Niccolo Mariani; Julian Carretero; Fernando Lopez-Rios; Robin Lovell-Badge; Montse Sanchez-Cespedes
Journal:  Cancer Res       Date:  2011-11-14       Impact factor: 12.701

Review 7.  Trophinin: what embryo implantation teaches us about human cancer.

Authors:  Michiko N Fukuda; Kazuhiro Sugihara; Jun Nakayama
Journal:  Cancer Biol Ther       Date:  2008-08       Impact factor: 4.742

8.  Down-regulation of CXCR7 inhibits the growth and lung metastasis of human hepatocellular carcinoma cells with highly metastatic potential.

Authors:  Tong-Chun Xue; Rong-Xin Chen; Dan Han; Jie Chen; Qiong Xue; Dong-Mei Gao; Rui-Xia Sun; Zhao-You Tang; Sheng-Long Ye
Journal:  Exp Ther Med       Date:  2011-09-29       Impact factor: 2.447

9.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

10.  Evidence of sex difference in DNA synthesis in hepatocellular carcinoma.

Authors:  K Tarao; A Shimizu; M Harada; T Ono; Y Kuni; S Ohkawa; Y Ito; S Tamai; K Iimori; Y Sugimasa
Journal:  Jpn J Cancer Res       Date:  1991-08
View more
  8 in total

1.  Does the Sex-Determining Region on the Y Chromosome (SRY) Correlate with Gender Disparity in Liver Disease?

Authors:  Xu-Feng Zhang; Yi Lv
Journal:  Dig Dis Sci       Date:  2015-02-10       Impact factor: 3.199

Review 2.  CircRNAs: a regulator of cellular stress.

Authors:  Joseph W Fischer; Anthony K L Leung
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-01-17       Impact factor: 8.250

3.  Bioinformatics analysis of SOXF family genes reveals potential regulatory mechanism and diagnostic value in cancers.

Authors:  Dan Wu; Chuan Jiang; Jing-Jing Zheng; De-Sheng Luo; Ji Ma; Hai-Feng Que; Chao Li; Chao Ma; Hui-Yong Wang; Wei Wang; Hong-Tao Xu
Journal:  Ann Transl Med       Date:  2022-06

4.  SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.

Authors:  Georg Richtig; Ariane Aigelsreiter; Daniela Schwarzenbacher; Anna Lena Ress; Jan Basri Adiprasito; Verena Stiegelbauer; Gerald Hoefler; Silvia Schauer; Tobias Kiesslich; Peter Kornprat; Thomas Winder; Florian Eisner; Armin Gerger; Herbert Stoeger; Rudolf Stauber; Carolin Lackner; Martin Pichler
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

Review 5.  Advance of SOX Transcription Factors in Hepatocellular Carcinoma: From Role, Tumor Immune Relevance to Targeted Therapy.

Authors:  Xiangyuan Luo; Xiaoyu Ji; Meng Xie; Tongyue Zhang; Yijun Wang; Mengyu Sun; Wenjie Huang; Limin Xia
Journal:  Cancers (Basel)       Date:  2022-02-24       Impact factor: 6.639

6.  Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular carcinoma.

Authors:  Zhiguo Zhang; Yanying Zhang; Yeying Wang; Lingling Xu; Wanju Xu
Journal:  Onco Targets Ther       Date:  2015-12-31       Impact factor: 4.147

7.  Upregulated SOX9 expression indicates worse prognosis in solid tumors: a systematic review and meta-analysis.

Authors:  Haihua Ruan; Shuangyan Hu; Hongyu Zhang; Gang Du; Xiaoting Li; Xiaobo Li; Xichuan Li
Journal:  Oncotarget       Date:  2017-11-06

Review 8.  SOX9 Stem-Cell Factor: Clinical and Functional Relevance in Cancer.

Authors:  Maribel Aguilar-Medina; Mariana Avendaño-Félix; Erik Lizárraga-Verdugo; Mercedes Bermúdez; José Geovanni Romero-Quintana; Rosalío Ramos-Payan; Erika Ruíz-García; César López-Camarillo
Journal:  J Oncol       Date:  2019-04-01       Impact factor: 4.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.